NEW YORK CITY, NY / ACCESS Newswire / November 6, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Lamb Weston Holdings, Inc. ("Lamb Weston" or "the Company") (NYSE:LW). Investors who purchased Lamb Weston securities prior to July 25, 2023, and continue to hold to the present, are […]

Portnoy Law Firm Announces Class Action on Behalf of CarMax, Inc.. Investors GlobeNewswire November 06, 2025 LOS ANGELES, Nov. 06, 2025 (GLOBE NEWSWIRE) — The Portnoy Law Firm advises CarMax, Inc., (“CarMax” or the “Company”) (NYSE: KMX) investors off a class action on behalf of investors that bought securities between March 5, 2024 and October

NEW YORK CITY, NY / ACCESS Newswire / November 6, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of BellRing Brands, Inc. ("BellRing" or "the Company") (NYSE:BRBR). Investors who purchased BellRing securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/BRBR.

NEW YORK CITY, NEW YORK / ACCESS Newswire / November 6, 2025 / Dentures have come a long way from the days of bulky, uncomfortable appliances, with modern options designed to look natural and feel more secure. Dentists in Fort Worth and around the globe have access to advanced technology, including digital design and 3D

With the stories of people affected by attacks on reproductive health care continuing to shape public opinion, Abortion in America is expanding its leadership to support storytellers and spotlight the harms caused by abortion bans. Abortion in America, a growing national effort co-founded in 2024 by the late Cecile Richards, Kaitlyn Joshua, and Lauren Peterson

NEW YORK CITY, NY / ACCESS Newswire / November 6, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Alector, Inc. ("Alector" or "the Company") (NASDAQ:ALEC). Investors who purchased Alector securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/ALEC. Investigation

NEW YORK CITY, NY / ACCESS Newswire / November 6, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Manhattan Associates, Inc. ("Manhattan Associates" or "the Company") (NASDAQ:MANH). Investors who purchased Manhattan Associates securities prior to October 22, 2024, and continue to hold to the present, are encouraged

NEW YORK CITY, NY / ACCESS Newswire / November 6, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Innodata Inc. ("Innodata" or "the Company") (NASDAQ:INOD). Investors who purchased Innodata securities prior to May 9, 2019, and continue to hold to the present, are encouraged to obtain additional

(Copenhagen:GMAB),(LSE:0MGB), November 6, 2025 Copenhagen, Denmark; Interim Report for the Nine Months Ended September 30, 2025 Highlights Announcement of Genmab's proposed acquisition of Merus N.V. (Merus) Genmab revenue increased 21% compared to the first nine months of 2024, to $2,662 million FDA granted BTD to Rina-S(R) in advanced endometrial cancer Epcoritamab Phase 3 EPCORE(R) FL-1

NEW YORK CITY, NY / ACCESS Newswire / November 6, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Coty, Inc. ("Coty" or "the Company") (NYSE:COTY). Investors who purchased Coty securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/COTY. Investigation